NCT05684887

Brief Summary

According to the WHO, contact tracing - along with robust testing, isolation, and care of cases is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19. Contact tracing, however, has a number of challenges. These include incomplete identification of contacts, inefficiencies in paper-based reporting systems, complex data management requirements, and delays in the identification of contacts and testing of contacts. In many settings, contact tracing has proven to be too resource-intensive to implement at scale, especially with higher levels of community transmission, highlighting the need for more efficient contact tracing approaches. Digital tools afford the possibility of strengthening contact tracing for COVID-19, in a more efficient way. However, there is limited evidence of the effectiveness and impact of these tools in the COVID-19 response, including contact tracing. This study proposes to compare the cascade of care between two strategies for COVID-19 contact tracing of SARS-CoV-2 infected index patients in Cameroon. In one strategy (intervention), the health facilities and health district testing units will implement contact tracing using a digital tool developed to support the tracing and testing of contacts (addition of a digital contact tracing module to the main platform for COVID-19 testing in Cameroon (Mamal Pro app)). This strategy will be compared to the standard contact tracing process (control), based on the current routine approach (use of the Mamal Pro application without the digital contact tracing module).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
433

participants targeted

Target at P75+ for not_applicable covid19

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

22 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 18, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 13, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2023

Completed
Last Updated

December 18, 2023

Status Verified

December 1, 2023

Enrollment Period

5 months

First QC Date

January 9, 2023

Last Update Submit

December 12, 2023

Conditions

Keywords

COVID-19Contact TracingmHealth

Outcome Measures

Primary Outcomes (1)

  • Successful contact tracing

    The primary outcome is the proportion of contacts declared by the index case who are successfully called by the district contact tracing unit and the proportion of contacts who receive SARS-CoV-2 testing, as per MOH standard testing procedures.

    10 days

Secondary Outcomes (6)

  • Contacts testing positive for SARS-CoV-2 infection.

    10 days

  • Feasibility of the intervention model of contact tracing

    4 months

  • Acceptability intervention model of contact tracing by the index cases (negative and positive) and health care workers

    4 months

  • Cost of the intervention

    4 months

  • Timely communication with contacts

    4 months

  • +1 more secondary outcomes

Study Arms (2)

Standard of care model (SOC)

NO INTERVENTION

This model is based on the standard of care recommended by the Cameroon National COVID-19 response program.

Intervention model (ITV)

EXPERIMENTAL

Implementation of the contact tracing using a digitalized process (addition of the Mamal Pro digital contact tracing module to the Mamal Pro app).

Other: Digital based contact tracing

Interventions

* Listing of contacts by SARS-CoV-2 positive individuals in Mamal Pro app + verification and validation by a health care worker. * Immediate access to the contact list in Mamal Pro once validated by the health care worker. * Contacts are immediately notified by text message automatically sent to all contacts with phone numbers and later called by the HCWs responsible for carrying out the contact tracing at the district level. * Contacts will be invited to go to the nearest testing facilities/units to get tested. * Those who are unable or refuse to come for testing are followed up by phone for 10 days for the occurrence of COVID-19 symptoms. * Information about the contact tracing process during communication with contacts are recorded in Mamal Pro digital contact tracing module.

Intervention model (ITV)

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All contacts listed by individuals registered in the Mamal Pro app for testing, who test positive for SARS-CoV-2 in the selected health district testing units and health facilities in Cameroon.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (22)

Bonanjo Integrated Health Center

Douala, Littoral Region, Cameroon

Location

Bonassama District COVID testing unit

Douala, Littoral Region, Cameroon

Location

Bonassama district hospital

Douala, Littoral Region, Cameroon

Location

Cité des palmiers District COVID testing unit

Douala, Littoral Region, Cameroon

Location

Cité des palmiers district hospital

Douala, Littoral Region, Cameroon

Location

CMA Bonamoussadi

Douala, Littoral Region, Cameroon

Location

CMA Nyala

Douala, Littoral Region, Cameroon

Location

CMA Soboum hospital

Douala, Littoral Region, Cameroon

Location

Deido District COVID testing unit

Douala, Littoral Region, Cameroon

Location

Deido district hospital

Douala, Littoral Region, Cameroon

Location

General Hospital Douala

Douala, Littoral Region, Cameroon

Location

Gynecological-Obstetric and Pediatric Hospital Douala (HGOPED)

Douala, Littoral Region, Cameroon

Location

Japoma District COVID testing unit

Douala, Littoral Region, Cameroon

Location

Laquintinie Hospital

Douala, Littoral Region, Cameroon

Location

Logbaba District COVID testing unit

Douala, Littoral Region, Cameroon

Location

Logbaba district hospital

Douala, Littoral Region, Cameroon

Location

Mbangue District COVID testing unit

Douala, Littoral Region, Cameroon

Location

Mboppi Baptist hospital

Douala, Littoral Region, Cameroon

Location

New Bell District COVID testing unit

Douala, Littoral Region, Cameroon

Location

New Bell district hospital

Douala, Littoral Region, Cameroon

Location

Nylon District COVID testing unit

Douala, Littoral Region, Cameroon

Location

Nylon district hospital

Douala, Littoral Region, Cameroon

Location

Related Publications (2)

  • Songane M, Tchakounte Youngui B, Mambo A, Bonabe G, Djikeussi T, Epee E, Tsigaing PN, Ndongo MLA, Mayap Njoukam C, Kana R, Tenkeu SZ, Simo L, Kouatchouang AV, Machekano R, Zoung-Kanyi Bissek AC, Tchendjou P, Tiam A, Guay L, Suleiman K, Akinwusi O, Kadam R, Akugizibwe P, Mukherjee S, Woelk G, Tchounga B. Using an app for COVID-19 contact tracing costs less per person traced than manual tracing: microcosting analysis of a randomised trial in Cameroon. BMJ Public Health. 2025 Jan 21;2(Suppl 1):e001064. doi: 10.1136/bmjph-2024-001064. eCollection 2024 Jul.

  • Tchakounte Youngui B, Mambo A, Machekano R, Kana R, Epee E, Tenkeu SZ, Tsigaing PN, Ndongo MLA, Njoukam CM, Bichara L, Katcho TD, Mbunka MA, Longla TA, Simo L, Kouatchouang AV, Tchendjou P, Tiam A, Guay L, Suleiman K, Akinwusi O, Kadam R, Akugizibwe P, Songane M, Woelk G, Tchounga BK; DTECT study group. Improving COVID-19 contact tracing and testing of exposed individuals in Cameroon using digital health technology: a cluster randomised trial. EClinicalMedicine. 2024 Jul 13;74:102730. doi: 10.1016/j.eclinm.2024.102730. eCollection 2024 Aug.

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Boris Tchakounte Youngui, MD, MPH

    Elizabeth Glaser Pediatric AIDS Foundation

    PRINCIPAL INVESTIGATOR
  • Godfrey Woelk, PhD, MCOMMH

    Elizabeth Glaser Pediatric AIDS Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This is a cluster randomized trial conducted in eight (8) Health Districts with a high number of people being tested for SARS-CoV-2 in the Littoral region in Cameroon, comparing two strategies for COVID-19 contact tracing of SARS-CoV-2 infected index patients: * The standard of care (SOC) implements the contact tracing using a manual process based on current routine approach (use of the Mamal Pro application without digital contact tracing module). * The intervention (ITV) will implement the contact tracing using a digitalized process (addition of the Mamal Pro digital contact tracing module to the Mamal Pro app). The randomization unit (cluster) will be the district with selected testing units and/or health facilities where SARS-CoV-2 infected patients (index cases) are diagnosed.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2023

First Posted

January 13, 2023

Study Start

October 18, 2022

Primary Completion

March 31, 2023

Study Completion

July 30, 2023

Last Updated

December 18, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations